Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-062191
Filing Date
2026-05-28
Accepted
2026-05-28 17:06:28
Documents
3
Period of Report
2026-05-28

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea029265001-6k_ascentage.htm 6-K 10316
2 ANNOUNCEMENT DATED MAY 28, 2026 ea029265001ex99-1_ascentage.htm EX-99.1 14247
3 GRAPHIC image_002.jpg GRAPHIC 5135
  Complete submission text file 0001213900-26-062191.txt   32953
Mailing Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU China
Business Address 68 XINQING ROAD SUZHOU INDUSTRIAL PARK SUZHOU , JIANGSU China 86 512 8555 7777
ASCENTAGE PHARMA GROUP INTERNATIONAL (Filer) CIK: 0002023311 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42484 | Film No.: 261037724
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)